
PhaseBio Pharmaceuticals PHAS
Quartalsbericht 2022-Q2
hinzugefügt 12.08.2022
PhaseBio Pharmaceuticals Kurshistorie 2011-2026 | PHAS
Kurshistorie Jährlich PhaseBio Pharmaceuticals
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2.61 | 3.36 | 6.11 | 3.09 | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 6.11 | 2.61 | 3.79 |
Kurshistorie anderer Aktien in der Pharmaeinzelhändler
| Name | Kurshistorie | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
18.2 | - | 2.43 % | $ 254 M | ||
|
Graybug Vision
GRAY
|
0.44 | - | -11.23 % | $ 9.65 M | ||
|
Apellis Pharmaceuticals
APLS
|
22 | $ 20.16 | -2.61 % | $ 2.54 B | ||
|
Aptorum Group Limited
APM
|
0.75 | $ 0.79 | -6.17 % | $ 4.31 M | ||
|
I-Mab
IMAB
|
0.68 | - | - | $ 866 M | ||
|
Acer Therapeutics
ACER
|
0.77 | - | 2.71 % | $ 14 M | ||
|
Biophytis SA
BPTS
|
0.33 | - | -13.47 % | $ 169 M | ||
|
Ampio Pharmaceuticals
AMPE
|
0.82 | - | -11.43 % | $ 502 K | ||
|
AbCellera Biologics
ABCL
|
3.22 | $ 3.71 | -2.88 % | $ 1.11 B | ||
|
Athersys
ATHX
|
0.9 | - | 3.77 % | $ 22.4 M | ||
|
Midatech Pharma plc
MTP
|
0.29 | - | -18.52 % | $ 27.3 M | ||
|
AVEO Pharmaceuticals
AVEO
|
3.54 | - | - | $ 521 M | ||
|
Axsome Therapeutics
AXSM
|
174 | $ 164.05 | -1.4 % | $ 8.16 B | ||
|
Brainstorm Cell Therapeutics
BCLI
|
1.26 | - | -2.5 % | $ 5.88 M | ||
|
BioDelivery Sciences International
BDSI
|
3.1 | - | -4.8 % | $ 255 M | ||
|
Burford Capital Limited
BUR
|
10.6 | $ 8.55 | -2.06 % | $ 1.39 B | ||
|
BridgeBio Pharma
BBIO
|
68.4 | $ 64.53 | -1.48 % | $ 12.4 B | ||
|
Adverum Biotechnologies
ADVM
|
3.86 | - | - | $ 86.2 M | ||
|
CymaBay Therapeutics
CBAY
|
32.3 | - | - | $ 3.45 B | ||
|
Avid Bioservices
CDMO
|
6.7 | - | - | $ 789 M | ||
|
ARCA biopharma
ABIO
|
28.8 | - | 1052.0 % | $ 415 M | ||
|
BioMarin Pharmaceutical
BMRN
|
61 | $ 58.53 | -2.03 % | $ 11.2 B | ||
|
Checkpoint Therapeutics
CKPT
|
4.04 | - | - | $ 169 M | ||
|
Caladrius Biosciences
CLBS
|
0.43 | - | -16.75 % | $ 25.8 M | ||
|
Alpine Immune Sciences
ALPN
|
8.04 | - | - | $ 2.17 B | ||
|
Clovis Oncology
CLVS
|
2.04 | - | -7.23 % | $ 13 M | ||
|
Acorda Therapeutics
ACOR
|
13.5 | - | -24.86 % | $ 820 K | ||
|
Checkmate Pharmaceuticals
CMPI
|
2.44 | - | - | $ 231 M | ||
|
Acasti Pharma
ACST
|
3.37 | - | 4.01 % | $ 150 M | ||
|
CTI BioPharma Corp.
CTIC
|
4.8 | - | - | $ 1.2 B | ||
|
CohBar
CWBR
|
1.83 | - | -15.44 % | $ 2.2 M | ||
|
Cyclacel Pharmaceuticals
CYCC
|
0.25 | - | -5.98 % | $ 34.1 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
4.9 | - | -4.36 % | $ 27 M | ||
|
Cabaletta Bio
CABA
|
17.5 | $ 3.25 | -1.52 % | $ 3.8 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
14.1 | - | - | $ 2.18 B | ||
|
CureVac N.V.
CVAC
|
19.3 | - | - | $ 867 M | ||
|
Capricor Therapeutics
CAPR
|
5.8 | $ 25.84 | -3.8 % | $ 692 M | ||
|
Aeterna Zentaris
AEZS
|
5.72 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
13 | - | -10.17 % | $ 12.2 K | ||
|
Codexis
CDXS
|
3.97 | $ 0.98 | -3.92 % | $ 71.9 M | ||
|
Certara
CERT
|
6.72 | $ 7.24 | 2.7 % | $ 1.16 B | ||
|
Aeglea BioTherapeutics
AGLE
|
12 | - | - | $ 1.01 B | ||
|
Entasis Therapeutics Holdings
ETTX
|
1.7 | - | - | $ 105 M | ||
|
Evofem Biosciences
EVFM
|
0.8 | - | 7.55 % | $ 38.1 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.3 | - | - | $ 26.5 M | ||
|
Coherus BioSciences
CHRS
|
2.22 | $ 1.65 | - | $ 155 M | ||
|
Evelo Biosciences
EVLO
|
0.31 | - | -14.46 % | $ 27.9 M |